The American Heart Association’s renowned journal Circulation has interviewed The George Institute for Global Health’s Chief Scientist, Professor Anushka Patel, in a special edition focusing on women and heart disease.
Friend of The George Institute for Global Health, June Oscar AO (pictured above, right), will become Australia’s new Aboriginal and Torres Strait Islander Social Justice Commissioner starting in April.
Today marks the official release of the report, ‘Low Vision, quality of life and independence: A review of the evidence on aids and technologies’ by Macular Disease Foundation Australia produced in collaboration with The George Institute for Global Health.
The George Institute for Global Health and the University of New South Wales (UNSW) today announced their intention to form a strategic collaboration to bolster high-impact medical research and transform lives around the world, a priority of both organisations.
Type 2 diabetes often causes damaging effects to the kidneys, sometimes resulting in the need for dialysis or kidney transplantation. The ongoing CANVAS-R trial is testing whether canagliflozin -- a member of a new class of diabetes treatments known as sodium glucose co-transporter 2 (SGLT2) inhibitors -- can slow kidney function decline and provide other benefits to diabetic patients.